MGY | ||
---|---|---|
OUTLOOK RATING 1..100 | 12 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 46 Fair valued | |
PROFIT vs RISK RATING 1..100 | 23 | |
SMR RATING 1..100 | 44 | |
PRICE GROWTH RATING 1..100 | 43 | |
P/E GROWTH RATING 1..100 | 12 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CVY | MGY | |
---|---|---|
RSI ODDS (%) | 11 days ago88% | 11 days ago89% |
Stochastic ODDS (%) | 11 days ago77% | 11 days ago74% |
Momentum ODDS (%) | 11 days ago85% | 11 days ago79% |
MACD ODDS (%) | 11 days ago90% | 11 days ago75% |
TrendWeek ODDS (%) | 11 days ago82% | 11 days ago76% |
TrendMonth ODDS (%) | 11 days ago79% | 11 days ago73% |
Advances ODDS (%) | 16 days ago83% | 11 days ago72% |
Declines ODDS (%) | 12 days ago80% | 23 days ago75% |
BollingerBands ODDS (%) | N/A | 11 days ago76% |
Aroon ODDS (%) | 11 days ago73% | 11 days ago85% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CLVRX | 33.12 | 0.24 | +0.73% |
Calvert US Large Cap Value Rspnb Idx R6 | |||
EQNTX | 21.67 | 0.12 | +0.56% |
MFS Equity Income R3 | |||
IEAOX | 11.99 | 0.05 | +0.42% |
Lazard International Equity Advtg Open | |||
RYVPX | 7.85 | 0.03 | +0.38% |
Royce Smaller-Companies Growth Svc | |||
BHSRX | 62.05 | N/A | N/A |
BlackRock Health Sciences Opps R |
A.I.dvisor indicates that over the last year, CVY has been closely correlated with MGY. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if CVY jumps, then MGY could also see price increases.